Table 2.
CIs (combination indices) (eq. 1) and DRIs obtained using CompuSyn software to analyse OVCAR4 ovarian cell viability inhibition resulting from treatment with the combination of vit D (0.0015–0.153 μg/mL) and different geographical sources of P (1–8400 μg/mL) for 48 h
At the level of Effective dose that induce 50% cellular viability inhibition | |||||||
---|---|---|---|---|---|---|---|
CI value | Concentration of each drug alone (μM) | Concentration of each drug in combination (μM) | DRI Vit D |
DRI of corresponding P |
|||
IC50 of Vit D (μg/mL) |
IC50 of selected geographical species of P (μg/mL) |
IC50 of Vit D (μg/mL) |
IC50 of selected geographical species of P (μg/mL) |
||||
Ger P + Vit D | 0.984 | 0.035 | 100.355 | 0.018 | 47.451 | 2.11 | 1.9 |
Egy P + Vit D | 0.866 | 0.035 | 86.064 | 0.014 | 38.704 | 2.39 | 2.22 |
Fre P + Vit D | 0.891 | 0.035 | 75.040 | 0.014 | 36.989 | 2.50 | 2.02 |
Equation 1, combination index32: CI = E (ca.) E (da) + E (cb) E (db)
Where; CI = combination index
E (ca.) = effect for drug a in combination
E (cb) = effect for drug b in combination
E (da) = effect of drug a alone
E (db) = effect of drug b alone